Saturday, December 02, 2017 8:35:11 PM
I took the info from their presented timeline, (on the website) which i copied and pasted below, although it did not come out in the same format.
Cannabis Cream (CanaPsor014)
Development Plan Timeline
2017 2018 2019
Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Completion human
safety and PK/PD study
(Phase 1)
IRB approval 6
week efficacy
study (Phase 2)
6 week human efficacy study
single or multicenter trial
(Phase 2)
Pre-IND
meeting
request
TLR
(Phase 2)
Final results
and analysis
(Phase 2)
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM